ACE Report Cover
Dilatation combined with steroid injections equivalent to steroid in adhesive capsulitis
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
SHOULDER & ELBOW
Dilatation combined with steroid injections equivalent to steroid in adhesive capsulitis .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2013;1(2):149 BMC Musculoskelet Disord. 2008 Apr 19;9:53.
Autori che hanno contribuito

EK Tveita R Tariq S Sesseng NG Juel E Bautz-Holter

76 patients diagnosed with adhesive capsulitis, having predominantly 1 shoulder pain for >3 months in the last 2 years, were randomized to undergo hydrodilatation with corticosteroid injection or just corticosteroid intra-articular injection. This study aimed to compare the clinical results between techniques. At 6 weeks, no major significant between-group differences in most of the outcome measures were recorded. There was a similar degree of improvement from baseline in both of the treatment groups, hence questioning the role of hydrodilation in management of adhesive capsulitis.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Non-Industry funded
Sponsor:
Research Council of Norway, the University of Oslo and Ulleval University Hospital
Conflicts:
None disclosed

Rischio di pregiudizio

6/10

Criteri di segnalazione

17/21

Indice di fragilità

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

2/4

Randomization

2/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

5/5

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

Evidence has suggested that the etiology of patients with adhesive capsulitis may result from the contractions of the shoulder and intraarticular adhesions. Hydrodilatation of the glenohumeral joint has thus been advocated for improvement of shoulder pain and range of motion in these patients. However, evidence remains inconclusive due to methodological issues. This study investigated the effect of hydrodilatation on the overall treatment effects of a combined dilatation and steroid injection procedure.

Qual era la domanda di ricerca principale?

Are there clinical differences between patients receiving dilatation (DIL) with a corticosteroid and patients receiving Injection (INJ) of a corticosteroid in the treatment of adhesive capsulitis?

Caratteristiche dello studio +
Population:
76 patients (18-70) with diagnosis of adhesive capsulitis, pain in one shoulder lasting >3 months, and limited passive movement in glenohumeral joint >30 degrees (versus opposite shoulder) in 2 of: forward flexion, abduction, external rotation.
Intervention:
Dilatation (DIL): Injection was comprised of: 4 ml of contrast dye, 2 ml triamcinolone acetonide, 4 ml local anesthetic and 10 ml physiological saline. Injection into the joint was performed slowly, and was paused upon resistance before continuing. This technique facilitated gradual joint distension and rupture. 3 injections were administered at two-week intervals (n=39; Mean age: 52+/-7; 26 females)
Comparison:
Injection (INJ): Following location of desired position (with fluoroscopy), 3-4 mL of contrast dye was injected, followed by 2 mL triamcinolone acetonide, and 3-4 mL of local anesthetic (bupivacaine, hydrochloride, Marcain 5mg/mL, Astra-Zeneca). Patients were administered 3 injections at two-week intervals. (n=37; Mean age: 51+/-6; 19 females)
Outcomes:
Outcomes included the Shoulder Pain and Disability Index (SPADI) and measurement of active and passive range of motion (AROM and PROM)in four directions: forward flexion, abduction from standing, external/internal rotation from 45 deg abduction (supine position).
Methods:
RCT: Prospective, Single-Center, Open trial
Time:
Patients were followed up 6 weeks after last injection.
Quali erano i risultati importanti?
  • Both groups had comparable clinical improvements in Shoulder Pain and Disability Index (SPADI), passive range of motion (PROM) and active range of motion (AROM) from baseline (p>0.05).
  • The mean difference in SPADI scores from baseline was 3 points (95% CI: -5 to 11) favouring the DIL group (p>0.05).
  • 13 and 9 patients in the INJ and DIL groups, respectively, reported flushing or disturbances with heat regulation. 20 and 14 patients, respectively, reported pain upon injection.
Che cosa devo ricordare di più?

Similar improvements from baseline in Shoulder Pain and Disability Index (SPADI), passive range of motion (PROM) and active range of motion (AROM) were observed in both the hydrodilatation and control groups.

Come influenzerà l'assistenza ai miei pazienti?

The results indicated that hydrodilatation did not provide any additional clinical benefits in patients with adhesive capsulitis, but may have an important treatment effect in some selected cases. Therefore, there is a need for future trials investigating the long-term effects of hydrodilatation.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. Dilatation combined with steroid injections equivalent to steroid in adhesive capsulitis. OE Journal. 2013;1(2):149. Available from: https://myorthoevidence.com/AceReport/Show/dilatation-combined-with-steroid-injections-equivalent-to-steroid-in-adhesive-capsulitis

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report